Your browser doesn't support javascript.
loading
Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues.
Beedie, Shaunna L; Peer, Cody J; Pisle, Steven; Gardner, Erin R; Mahony, Chris; Barnett, Shelby; Ambrozak, Agnieszka; Gütschow, Michael; Chau, Cindy H; Vargesson, Neil; Figg, William D.
Afiliação
  • Beedie SL; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
  • Peer CJ; Clinical Pharmacology Program, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Pisle S; Clinical Pharmacology Program, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Gardner ER; Clinical Pharmacology Program, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Mahony C; School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
  • Barnett S; School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
  • Ambrozak A; Pharmaceutical Institute, University of Bonn, Bonn, Germany.
  • Gütschow M; Pharmaceutical Institute, University of Bonn, Bonn, Germany.
  • Chau CH; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Vargesson N; School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom. figgw@helix.nih.gov n.vargesson@abdn.ac.uk.
  • Figg WD; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. Clinical Pharmacology Program, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. figgw@helix.nih.gov n.vargesson@abdn.ac.uk
Mol Cancer Ther ; 14(10): 2228-37, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26269604
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Inibidores da Angiogênese / Hidrocarbonetos Fluorados / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Inibidores da Angiogênese / Hidrocarbonetos Fluorados / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article